Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: Beneficial or detrimental?

Niki Katsiki, Konstantinos Tziomalos, Yiannis Chatzizisis, Moses Elisaf, Apostolos I. Hatzitolios

Research output: Contribution to journalReview article

44 Citations (Scopus)

Abstract

Vascular cell apoptosis, an active form of programmed cell death, plays an integral role in atherosclerosis and in-stent restenosis after angioplasty, thus promoting the precipitation of acute cardiovascular events. Beyond their cholesterol-lowering effects, HMG-CoA reductase inhibitors, or statins, have been persistently reported to influence the apoptotic process.In this review we discuss the effect of statin treatment on vascular cell apoptosis, and therefore on atherosclerosis development, plaque rupture and in-stent restenosis, based on the results of up-to-date experimental and clinical studies. Lipophilic statins have been shown to induce apoptosis in a variety of cell types, including vascular smooth muscle cells and endothelial cells, whereas hydrophilic statins (rosuvastatin and pravastatin) have not. The clinical importance of statin induced apoptosis remains controversial, as it may blunt vascular wall thickening in the early stages of atherosclerosis or reduce the neointimal response to injury on the one hand, but on the other hand it may also promote destabilization of vulnerable plaques precipitating acute cardiovascular events.Current data support the initiation of statin treatment early enough to inhibit both the formation of atherosclerotic plaques (primary prevention) and in-stent restenosis (secondary prevention).

Original languageEnglish (US)
Pages (from-to)9-14
Number of pages6
JournalAtherosclerosis
Volume211
Issue number1
DOIs
StatePublished - Jul 1 2010

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Blood Vessels
Apoptosis
Stents
Atherosclerosis
Pravastatin
Atherosclerotic Plaques
Primary Prevention
Secondary Prevention
Vascular Smooth Muscle
Angioplasty
Smooth Muscle Myocytes
Rupture
Cell Death
Endothelial Cells
Cholesterol
Wounds and Injuries
Therapeutics

Keywords

  • Atherosclerosis
  • Restenosis
  • Statins
  • Vascular cell apoptosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis : Beneficial or detrimental? / Katsiki, Niki; Tziomalos, Konstantinos; Chatzizisis, Yiannis; Elisaf, Moses; Hatzitolios, Apostolos I.

In: Atherosclerosis, Vol. 211, No. 1, 01.07.2010, p. 9-14.

Research output: Contribution to journalReview article

Katsiki, Niki ; Tziomalos, Konstantinos ; Chatzizisis, Yiannis ; Elisaf, Moses ; Hatzitolios, Apostolos I. / Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis : Beneficial or detrimental?. In: Atherosclerosis. 2010 ; Vol. 211, No. 1. pp. 9-14.
@article{0154af09ee354d8095c6f364b26bd5ec,
title = "Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: Beneficial or detrimental?",
abstract = "Vascular cell apoptosis, an active form of programmed cell death, plays an integral role in atherosclerosis and in-stent restenosis after angioplasty, thus promoting the precipitation of acute cardiovascular events. Beyond their cholesterol-lowering effects, HMG-CoA reductase inhibitors, or statins, have been persistently reported to influence the apoptotic process.In this review we discuss the effect of statin treatment on vascular cell apoptosis, and therefore on atherosclerosis development, plaque rupture and in-stent restenosis, based on the results of up-to-date experimental and clinical studies. Lipophilic statins have been shown to induce apoptosis in a variety of cell types, including vascular smooth muscle cells and endothelial cells, whereas hydrophilic statins (rosuvastatin and pravastatin) have not. The clinical importance of statin induced apoptosis remains controversial, as it may blunt vascular wall thickening in the early stages of atherosclerosis or reduce the neointimal response to injury on the one hand, but on the other hand it may also promote destabilization of vulnerable plaques precipitating acute cardiovascular events.Current data support the initiation of statin treatment early enough to inhibit both the formation of atherosclerotic plaques (primary prevention) and in-stent restenosis (secondary prevention).",
keywords = "Atherosclerosis, Restenosis, Statins, Vascular cell apoptosis",
author = "Niki Katsiki and Konstantinos Tziomalos and Yiannis Chatzizisis and Moses Elisaf and Hatzitolios, {Apostolos I.}",
year = "2010",
month = "7",
day = "1",
doi = "10.1016/j.atherosclerosis.2009.12.028",
language = "English (US)",
volume = "211",
pages = "9--14",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis

T2 - Beneficial or detrimental?

AU - Katsiki, Niki

AU - Tziomalos, Konstantinos

AU - Chatzizisis, Yiannis

AU - Elisaf, Moses

AU - Hatzitolios, Apostolos I.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Vascular cell apoptosis, an active form of programmed cell death, plays an integral role in atherosclerosis and in-stent restenosis after angioplasty, thus promoting the precipitation of acute cardiovascular events. Beyond their cholesterol-lowering effects, HMG-CoA reductase inhibitors, or statins, have been persistently reported to influence the apoptotic process.In this review we discuss the effect of statin treatment on vascular cell apoptosis, and therefore on atherosclerosis development, plaque rupture and in-stent restenosis, based on the results of up-to-date experimental and clinical studies. Lipophilic statins have been shown to induce apoptosis in a variety of cell types, including vascular smooth muscle cells and endothelial cells, whereas hydrophilic statins (rosuvastatin and pravastatin) have not. The clinical importance of statin induced apoptosis remains controversial, as it may blunt vascular wall thickening in the early stages of atherosclerosis or reduce the neointimal response to injury on the one hand, but on the other hand it may also promote destabilization of vulnerable plaques precipitating acute cardiovascular events.Current data support the initiation of statin treatment early enough to inhibit both the formation of atherosclerotic plaques (primary prevention) and in-stent restenosis (secondary prevention).

AB - Vascular cell apoptosis, an active form of programmed cell death, plays an integral role in atherosclerosis and in-stent restenosis after angioplasty, thus promoting the precipitation of acute cardiovascular events. Beyond their cholesterol-lowering effects, HMG-CoA reductase inhibitors, or statins, have been persistently reported to influence the apoptotic process.In this review we discuss the effect of statin treatment on vascular cell apoptosis, and therefore on atherosclerosis development, plaque rupture and in-stent restenosis, based on the results of up-to-date experimental and clinical studies. Lipophilic statins have been shown to induce apoptosis in a variety of cell types, including vascular smooth muscle cells and endothelial cells, whereas hydrophilic statins (rosuvastatin and pravastatin) have not. The clinical importance of statin induced apoptosis remains controversial, as it may blunt vascular wall thickening in the early stages of atherosclerosis or reduce the neointimal response to injury on the one hand, but on the other hand it may also promote destabilization of vulnerable plaques precipitating acute cardiovascular events.Current data support the initiation of statin treatment early enough to inhibit both the formation of atherosclerotic plaques (primary prevention) and in-stent restenosis (secondary prevention).

KW - Atherosclerosis

KW - Restenosis

KW - Statins

KW - Vascular cell apoptosis

UR - http://www.scopus.com/inward/record.url?scp=77954314235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954314235&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2009.12.028

DO - 10.1016/j.atherosclerosis.2009.12.028

M3 - Review article

C2 - 20060525

AN - SCOPUS:77954314235

VL - 211

SP - 9

EP - 14

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -